Business · 19/12/2022Updated: 10/17/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting to Discuss COVID-19 Vaccination Regimens
Summary
The Food and Drug Administration (FDA) is hosting a public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) on January 26, 2023, to discuss future COVID-19 vaccination regimens. The public is invited to attend and provide input through an open public comment period.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →